Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Epithelial Pleural Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07510815
What this trial is testing

Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma

Who this might be right for
Malignant Pleural Mesotheliomas
Beijing Biotech 36
Testing effectiveness (Phase 2)UnknownNCT00002465
What this trial is testing

High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma

Who this might be right for
Breast CancerEndometrial CancerMalignant Mesothelioma
St. Vincent Medical Center - Los Angeles
Not applicableStudy completedNCT05324436
What this trial is testing

Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT02414269
What this trial is testing

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

Who this might be right for
Malignant Pleural DiseaseMesotheliomaMetastases+2 more
Memorial Sloan Kettering Cancer Center 113
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT02716272
What this trial is testing

Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients

Who this might be right for
Mesothelioma
Intergroupe Francophone de Cancerologie Thoracique 125
Not applicableStudy completedNCT04324437
What this trial is testing

ERAPID: Online Symptom Reporting in Lung Cancer

Who this might be right for
Thoracic CancerNon-small Cell Lung CancerSmall-cell Lung Cancer+1 more
University of Leeds 43
Testing effectiveness (Phase 2)Study completedNCT00700336
What this trial is testing

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)

Who this might be right for
Malignant Pleural MesotheliomaSolid Tumors
CanBas Co. Ltd. 69
Testing effectiveness (Phase 2)Study completedNCT01243632
What this trial is testing

Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment

Who this might be right for
Malignant Pleural Mesothelioma
Institute of Oncology Ljubljana 78
Early research (Phase 1)Study completedNCT01119664
What this trial is testing

Combination Gene Transfer and Chemotherapy

Who this might be right for
Mesothelioma
Abramson Cancer Center at Penn Medicine 40